Optimum bile acid treatment for rapid gall stone dissolution

Area of Science:

• Gastroenterology
• Hepatology
• Pharmacology

Background:

• Gallstones affect a significant portion of the population, necessitating effective dissolution therapies.
• Bile acid therapy is a primary medical approach for managing cholesterol gallstones.
• Optimizing bile acid regimens can improve treatment efficacy and patient outcomes.

Purpose of the Study:

• To identify the optimal bile acid regimen for rapid gallstone dissolution.
• To compare the efficacy of chenodeoxycholic acid (CDCA) and ursodeoxycholic acid (UDCA) administration timing.
• To evaluate the effectiveness of combination bile acid therapy.

Main Methods:

• 48 gallstone patients were randomized into four groups receiving CDCA or UDCA at bedtime or mealtime.
• An additional 10 patients received a combination of CDCA and UDCA at bedtime.
• Gallstone dissolution rates were assessed at 6 and 12 months using oral cholecystography.

Main Results:

• UDCA showed higher dissolution rates than CDCA at six months (78% vs. 48%, p<0.01).
• Bedtime administration was more effective than mealtime administration (69% vs. 39%, p<0.02).
• Combination therapy was faster than CDCA alone at 6 and 12 months (82% vs. 36%, p<0.05 and 100% vs. 54%, p<0.05).

Conclusions:

• Bile acid treatment is most effective for patients with small gallstones (less than 8 mm).
• Bedtime administration of combined UDCA and CDCA appears to be the most effective and safe gallstone dissolution regimen.
• Further research may explore long-term efficacy and safety profiles of optimized bile acid therapies.